{"id":38690,"date":"2021-03-01T09:59:40","date_gmt":"2021-03-01T09:59:40","guid":{"rendered":"https:\/\/copleyv3.fifteen.dev\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/"},"modified":"2021-03-01T09:59:40","modified_gmt":"2021-03-01T09:59:40","slug":"copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio","status":"publish","type":"post","link":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/","title":{"rendered":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio"},"content":{"rendered":"<div class=\"entry-content\"><p><strong><span style=\"text-decoration: underline;\">01 March 2021, Nottingham, UK<\/span>:<\/strong> Copley Scientific, the global leaders in inhaler testing equipment, is marking the company\u2019s 75th anniversary with a significant upgrade of its comprehensive, integrated range for measuring the critical attributes of orally inhaled and nasal drug products (OINDPs), notably delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD). The upgrade marks a major evolution in Copley\u2019s offering which now includes:<\/p>\n<ul>\n<li>new products to meet defined customer needs, from tools for workflow management such as the Inhaler Testing Workstation (ITW) to an updated portfolio for nasal drug product testing<\/li>\n<li>re-engineered core ancillaries, substantially updated with an emphasis on ease-of-use, efficiency, and productivity<\/li>\n<li>Inhalytix\u2122, a state-of-the-art, fully validated software package for generating APSD metrics in line with the latest pharmacopoeial specifications<\/li>\n<li>an expanded, fully revised version of the company\u2019s renowned, highly informative inhaler testing brochure.<\/li>\n<\/ul>\n<p>\u201cCopley brings unrivalled expertise to every aspect of OINDP testing,&#8221; said Mark Copley CEO. \u201cWe rigorously track changes in the regulatory landscape, and we listen to customers. The fully refreshed offering reflects these efforts. Our focus has been to make testing more straight forward and efficient, from bench space management to data analysis, equipment selection to test automation. \u00a0The new brochure guides customers through the increasingly complex world of OINDP testing and explains how to use all our products effectively, whether testing a generic in accordance with product-specific guidance or refining a test set-up for better <em>in vitro-in vivo correlations<\/em> (IVIVCs).\u201d<\/p>\n<p>Refreshed ancillaries are characterised by clean lines, small footprint designs, and the latest touchscreen technology, complete with icon-based menus. Critical flow controllers (the TPK range), breath actuated controllers (the BAC 2100) and breathing simulators (the BRS range) have all been updated. A switch to quick release connectors on all equipment makes it easy to rapidly establish a leak-free test set-up.<\/p>\n<p>New introductions range from the ITW, a handling aid for the various pieces of equipment used during inhaler testing, to accessories that work with Copley\u2019s automated shake and fire platforms to deliver highly reproducible nasal spray testing. The Copley brochure covers all aspects of DDU testing and APSD measurement, providing insight into the regulatory guidance and pharmacopoeial specifications associated with each. Advanced sections covering special applications and test set-ups for enhanced IVIVCs provide clear, concise advice on how to use the full range to optimise the testing of generic and innovator products, from R&amp;D through to QC.<\/p>\n<p>\u201cContinuous improvement is a Copley hallmark,\u201d said Mark Copley. \u201cOur new offering includes valuable upgrades that we\u2019re confident can have a real impact on the day-to-day efficiency and integrity of OINDP testing. Whether you are looking for state-of-the-art equipment or insight on how to optimise testing strategies and lab practice, we can help.\u201d<\/p>\n<p>Find out more about the full Copley range for OINDP testing at <a href=\"http:\/\/www.copleyscientific.com\">www.copleyscientific.com<\/a><\/p>\n<p><img decoding=\"async\" class=\"size-medium wp-image-12571 aligncenter\" src=\"https:\/\/www.copleyscientific.com\/wp-content\/smush-webp\/2021\/03\/Copley-Scientific-800x533.png.webp\" alt=\"Copley Inhaler Testing Product Updates 2021\" loading=\"lazy\" \/><\/p>\n<p style=\"text-align: center;\"><strong>CAPTION: <\/strong>Streamlined, intuitive ancillaries with touchscreen operation are a key feature of the upgraded Copley offering for OINDP testing.<\/p>\n<p style=\"text-align: center;\"><strong>ENDS<\/strong><\/p>\n<h3><strong>About Copley Scientific<\/strong><\/h3>\n<p>Copley Scientific is widely recognised as the world\u2019s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.<\/p>\n<p>Copley\u2019s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products &#8211; metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays &#8211; with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.<\/p>\n<p>Used from R&amp;D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.\u00a0 <a href=\"http:\/\/www.copleyscientific.com\">www.copleyscientific.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company\u2019s 75th anniversary with a significant upgrade of its comprehensive, integrated range for measuring the critical attributes of orally inhaled and nasal drug products (OINDPs), notably delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD). The upgrade&#8230; <br><a class=\"view-article\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/\">View Article<\/a>","protected":false},"author":1,"featured_media":38586,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[200,202],"tags":[219,221,232,234,235,249,254,274,276,281,282,295,303,312,328,329],"class_list":["post-38690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-200","category-corporate-zh-hans","tag-apsd-dry-powder-inhalers-dpis","tag-apsd-for-aqueous-droplet-inhalers-adis-zh-hans","tag-cup-coater-ngi-zh-hans-2","tag-bac-2100-zh-hans-2","tag-apsd-spacers-vhcs-zh-hans-3","tag-tpk-2100-zh-hans-2","tag-spu-2000-zh-hans-2","tag-ddu-dry-powder-inhalers-dpis-zh-hans","tag-apsd-mdis-bais-zh-hans-3","tag-apsd-ivivc-mdis-bais-dpis-nebulisers-zh-hans","tag-ddu-ivivc-mdis-bais-dpis-nebulisers-zh-hans-2","tag-ddu-facemask-testing-zh-hans-3","tag-ddu-aqueous-drop-inhalers-adis-zh-hans-2","tag-brs-1100-zh-hans-2","tag-alberta-idealised-nasal-inlet-aini","tag--itw"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio - Copley Scientific<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio - Copley Scientific\" \/>\n<meta property=\"og:description\" content=\"01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company\u2019s 75th anniversary with a significant upgrade of its comprehensive, integrated range for measuring the critical attributes of orally inhaled and nasal drug products (OINDPs), notably delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD). The upgrade... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Copley Scientific\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T09:59:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1-1200x800.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"fifteen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifteen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio - Copley Scientific","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/","og_locale":"zh_CN","og_type":"article","og_title":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio - Copley Scientific","og_description":"01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company\u2019s 75th anniversary with a significant upgrade of its comprehensive, integrated range for measuring the critical attributes of orally inhaled and nasal drug products (OINDPs), notably delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD). The upgrade... View Article","og_url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/","og_site_name":"Copley Scientific","article_published_time":"2021-03-01T09:59:40+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1-1200x800.png","type":"image\/png"}],"author":"fifteen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fifteen","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#article","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/"},"author":{"name":"fifteen","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"headline":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio","datePublished":"2021-03-01T09:59:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/"},"wordCount":680,"image":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1.png","keywords":["APSD Dry Powder Inhalers (DPIs)","APSD for Aqueous Droplet Inhalers (ADIs)","Cup Coater (NGI)","BAC 2100","APSD Spacers\/VHCs","TPK 2100","SPU 2000","DDU Dry Powder Inhalers (DPIs)","APSD MDIs\/BAIs","APSD IVIVC (MDIs\/BAIs\/DPIs &amp; Nebulisers)","DDU IVIVC (MDIs\/BAIs\/DPIs &amp; Nebulisers)","DDU Facemask Testing","DDU Aqueous Drop Inhalers (ADIs)","BRS 1100","Alberta Idealised Nasal Inlet (AINI)","\u5438\u5165\u5668\u6d4b\u8bd5\u5de5\u4f5c\u7ad9 (ITW)"],"articleSection":["\u5438\u5165\u5236\u5242\u8bd5\u9a8c","\u516c\u53f8"],"inLanguage":"zh-CN"},{"@type":"WebPage","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/","url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/","name":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio - Copley Scientific","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1.png","datePublished":"2021-03-01T09:59:40+00:00","author":{"@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"breadcrumb":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#primaryimage","url":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1.png","contentUrl":"https:\/\/www.copleyscientific.com\/wp-content\/uploads\/2021\/03\/Copley-Scientific-1.png","width":1732,"height":1155},{"@type":"BreadcrumbList","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/copley-announces-a-major-upgrade-of-the-worlds-go-to-inhaler-testing-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.copleyscientific.com\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"Copley announces a major upgrade of the world\u2019s \u2018go to\u2019 inhaler testing portfolio"}]},{"@type":"WebSite","@id":"https:\/\/www.copleyscientific.com\/#website","url":"https:\/\/www.copleyscientific.com\/","name":"Copley Scientific","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.copleyscientific.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Person","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c","name":"fifteen","image":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","caption":"fifteen"},"sameAs":["http:\/\/localhost:8888\/copley-v3"],"url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/author\/fifteen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=38690"}],"version-history":[{"count":0,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/media\/38586"}],"wp:attachment":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=38690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=38690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=38690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}